Hydrea Dosage
Generic name: hydroxyurea 500mg
Dosage form: capsule
Drug class: Antimetabolites
Medically reviewed by Drugs.com. Last updated on Aug 15, 2024.
Dosing Information
HYDREA is used alone or in conjunction with other antitumor agents or radiation therapy to treat neoplastic diseases. Individualize treatment based on tumor type, disease state, response to treatment, patient risk factors, and current clinical practice standards.
Base all dosage on the patient's actual or ideal weight, whichever is less.
HYDREA is a cytotoxic drug. Follow applicable special handling and disposal procedures.
Swallow HYDREA capsules whole. Do NOT open, break, or chew capsules because HYDREA is a cytotoxic drug.
Prophylactic administration of folic acid is recommended.
Monitor blood counts at least once a week during HYDREA therapy. Severe anemia must be corrected before initiating therapy with HYDREA.
Dose Modifications for Toxicity
Monitor for the following and reduce the dose or discontinue HYDREA accordingly:
- Myelosuppression
- Cutaneous vasculitis
Consider dose modifications for other toxicities.
Dose Modifications for Renal Impairment
Reduce the dose of HYDREA by 50% in patients with measured creatinine clearance of less than 60 mL/min or with end-stage renal disease (ESRD).
Creatinine Clearance (mL/min) |
Recommended HYDREA Initial Dose (mg/kg once daily) |
---|---|
≥60 |
15 |
<60 or ESRD* |
7.5 |
* On dialysis days, administer HYDREA to patients following hemodialysis.
Close monitoring of hematologic parameters is advised in these patients.
More about Hydrea (hydroxyurea)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (8)
- Drug images
- Side effects
- During pregnancy
- Generic availability
- Drug class: antimetabolites
- Breastfeeding
- En español
Patient resources
Other brands
Droxia, Xromi, Siklos, Mylocel
Professional resources
Other brands
Related treatment guides
See also:
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Sprycel
Sprycel is used to treat chronic myeloid leukemia and acute lymphoblastic leukemia. Learn about ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Tasigna
Tasigna (nilotinib) is used to treat Philadelphia chromosome positive chronic myeloid leukemia ...
Scemblix
Scemblix (asciminib) is an oral kinase inhibitor that may be used to treat adults with a type of ...
Bosulif
Bosulif is a kinase inhibitor that may be used to treat adults and some children aged 1 year and ...
Ponatinib
Ponatinib is used to treat chronic myeloid leukemia and Philadelphia chromosome positive acute ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.